April 1, 2024 · Form 4 insider transaction
Parsey Merdad sold 2,000 shares of Gilead Sciences, Inc. at $72.96 per share, a transaction worth $145.9K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
The sale transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on November 9, 2023.